Don bayani kawai — ba shawarar likita ba ne
Yaya tsananinsa?
Haɗarin mutuwa
Eh
Allurar rigakafi tana nan?
Lokacin zuwa alamomi
Ƙasashen da abin ya shafa
Annobar da ke gudana
Allurar rigakafi tana ba da kariya >95% kuma ana ba da shawarar ga dukkan matafiya. Ana daukar cutar ta hanyar jini, huldar jima'i, da kayan aikin likita masu gurbata. Ka guji jarfa, huda, da hanyoyin likita/hakori marasa tsabta a wuraren da ke da karancin kayayyaki.
Ciwon hanta B kwayar cuta ce da hepatitis B virus (HBV) ke haifarwa. Tana shafar hanta kuma tana iya zama cuta ta dindindin wanda ke haifar da cirrhosis da kansar hanta.
Alamomi | Yawan faruwa | Tsanani | Farawa |
|---|---|---|---|
| Gajiya | 70% | Dan kadan | Farkon cuta |
| Rashin son ci | 60% | Dan kadan | Farkon cuta |
| Rashin jin daɗi | 65% | Dan kadan | Farkon cuta |
| Tashin zuciya | 55% | Dan kadan | Farkon cuta |
| Ciwon gaɓoɓi | 25% | Dan kadan | Farkon cuta |
| Zazzabi | 30% | Dan kadan | Farkon cuta |
| Ciwon tsoka | 30% | Dan kadan | Farkon cuta |
| Amai | 35% | Dan kadan | Farkon cuta |
| Zawo | 15% | Dan kadan | Farkon cuta |
| Ciwon kai | 25% | Dan kadan | Farkon cuta |
| Kumburin haɗin gaɓoɓi | 10% | Dan kadan | Farkon cuta |
| Ƙurji | 15% | Dan kadan | Farkon cuta |
| Kumburin ƙwayoyin lymph | 10% | Dan kadan | Farkon cuta |
| Ciwon ciki | 50% | Matsakaici | Kololuwar cuta |
| Duhuwar fitsari | 45% | Matsakaici | Kololuwar cuta |
| Kumburin hanta | 50% | Dan kadan | Kololuwar cuta |
| Shanƙe | 40% | Matsakaici | Kololuwar cuta |
| Ƙaiƙayi | 20% | Dan kadan | Kololuwar cuta |
| Kumburin saifa | 15% | Dan kadan | Kololuwar cuta |
| Raguwar nauyi | 15% | Dan kadan | Kowane lokaci |
Ciwon hanta na B cuta ce mai hatsarin gaske ga hanta wanda kwayar cutar hanta B (HBV) ke haddasa shi, kwayar cutar DNA daga dangin Hepadnaviridae. Yana yaduwa ta hanyar jini da ruwan jiki (daga uwa zuwa jariri, jima'i, allura). Kusan mutane miliyan 296 ne ke dauke da cutar a duniya, kusan mutuwar 820,000/shekara saboda lalacewar hanta da kansa na hanta. Akwai allurar rigakafi mai inganci sosai.
Ciwon hanta na B (Hepatitis B) kwayar cutar HBV ce ke haddasa shi. Kwayar cutar tana da karfin yaduwa sau 50–100 fiye da HIV. Hanyoyin yaduwa: ta jini (needles, kayan aski, kayan aski na gargajiya), ta hanyar jima'i, da daga uwa zuwa jariri (vertical transmission). Kashi 90% na jarirai da suka kamu suna samun cuta ta dindindin (chronic infection). Najeriya tana da yawan kamuwa da cuta mai girma sosai — kusan kashi 8–10% na manya suna dauke da HBsAg. Hukumar Lafiya ta Duniya ta kiyasta miliyan 254 na masu cuta ta dindindin a duniya.
Allurar rigakafi tana samuwa a cikin jadawalin rigakafin yara na NPHCDA — allura a haihuwa (birth dose) tare da jerin allurai na farko (primary series). A Najeriya, allura ta haihuwa ita ce mabudin hana yaduwa daga uwa zuwa jariri. Cuta ce da dole a bayar da rahotonta.
Yellowing mai tsanani (jaundice) + ruduwar kwakwalwa (hepatic encephalopathy). Zubar da jini ba tare da dalili ba. Kumburin ciki (ascites). Amai na jini.
Alamomi da alamu mafi yawa
Lokacin kwanciyar cuta: Kwanaki 45–180. Mai tsanani: gajiya, yellowing na fata da idanu (jaundice/shanye), ciwo a gefen dama na ciki. Na dindindin (ba tare da alamun cuta ba tsawon shekaru da yawa): taurin hanta (cirrhosis), ciwon daji na hanta (hepatocellular carcinoma). Matsaloli a wajen hanta: kumburin jijiyoyin jini (polyarteritis nodosa), cutar koda (glomerulonephritis).
Sanin alamomi shine mataki na farko don amsa cikin sauri.
Matakan cutar hanta B:
Jadawalin gwajin jini: HBsAg ya bayyana mako 1–10 bayan kamuwa, kafin alamomi. Anti-HBc IgM na nuna kamuwa ta ɗan lokaci. Anti-HBs na nuna warkarwa da rigakafi.
Yadda ake gano wannan cutar
HBsAg (cuta mai aiki). Anti-HBs (kariya/rigakafi). Anti-HBc IgM/IgG. HBeAg. HBV-DNA. Duban ultrasound da gwajin AFP kowane wata 6 (binciken ciwon daji na hanta). Bayar da rahoto dole ne.
Hanyoyin magani da ake da su
Mai tsanani: tallafin jiki. Na dindindin: Tenofovir 245 mg/rana ko Entecavir 0.5–1 mg/rana. Pegylated interferon: zabi na wani lokaci. Manufar magani: rage HBV-DNA zuwa matakin da ba a iya gano shi.
Yawancin lokuta ana magance su yadda ya kamata tare da gano cutar da wuri.
Yadda za ka kare kanka
Allurar rigakafi: allura a haihuwa (cikin sa'o'i 24) + jerin allurai na farko. Tana cikin jadawalin NPHCDA. Rigakafi bayan fuskanci cutar: HBIG + allura cikin sa'o'i <12 (jarirai na uwaye masu HBsAg+). Gwajin duk mata masu ciki. A Najeriya, bukata ta musamman ita ce kara yawan allurar haihuwa (birth dose coverage) — har yanzu kasa.
Shirye-shirye shine mafi kyawun kariya.
A yi allurar rigakafi kafin tafiya zuwa Najeriya da sauran kasashen Yammacin Afirka. Twinrix (Hepatitis A+B). A guji ayyukan likita a wuraren da ba a tabbatar da tsafta ba. A guji kayan aski na gargajiya.
Ƙididdiga da bayanan yanki
Najeriya tana da kashi ~8–10% na kamuwa — daya daga cikin mafi girma a duniya. Yammacin Afirka baki daya tana da yawan kamuwa mai girma. Ingancin rigakafin yara yana rage kamuwa cikin sabon tsara amma manya da yawa har yanzu suna dauke da cutar ba tare da sanin hakan ba.
Wanene ke cikin haɗarin mafi girma
Uwa mai HBsAg (babban abin hadari a duniya), rashin allurar rigakafi, ma'aikatan kiwon lafiya, masu amfani da miyagun kwayoyi ta allura, masu abokan jima'i da yawa, MSM, mutanen gida, zama a yankunan da cutar ta yadu, mutanen da ake wanke musu jini.
Rikitarwa da za ta iya faruwa
Taurin hanta (cirrhosis): bayan shekaru 20–30 na cuta ta dindindin. Ciwon daji na hanta (hepatocellular carcinoma): hadari mai girma musamman a Najeriya saboda yawan kamuwa. Gazawar hanta (liver failure). A Najeriya, ciwon hanta na B yana daga cikin manyan dalilan ciwon daji na hanta.
Sakamakon da ake tsammani da murmurewa
Hasashen kamuwa ta ɗan lokaci: Fiye da 95% na manya masu ƙarfin rigakafi suna kawar da ƙwayar cutar da kansu. Mummunar cutar hanta tana faruwa a ƙasa da 1% na marasa lafiya amma tana da kashi 60–80% na mutuwa ba tare da dashen hanta ba.
Hasashen kamuwa na dindindin:
Haɗarin zama na dindindin yana da alaƙa da shekarun kamuwa: 90% a jariran da aka haifa, 30% a yara masu shekaru 1–5, ƙasa da 5% a manya.
Daga cikin masu ɗauke da ita na dindindin: 15–40% na haɓaka taurin hanta (cirrhosis), ciwon dajin hanta (HCC), ko gazawar hanta cikin shekaru da yawa.
Haɗarin HCC: sau 100 fiye da al'ummar da ba su kamu ba. Yawan HCC na shekara-shekara a cikin masu cirrhosis: 2–5%.
Da maganin rigakafin ƙwayoyin cuta (tenofovir, entecavir): an sami nasarar rage ƙwayoyin cuta a cikin fiye da 95%, akwai yiwuwar warkar da taurin hanta, haɗarin HCC ya ragu sosai amma bai ƙare ba.
Cikakkiyar warkarwa (ɓacewar HBsAg): An samu a ƙasa da 10% tare da maganin yanzu. HBV DNA na ci gaba da kasancewa a matsayin cccDNA a cikin ƙwayoyin hanta har abada.
Ana iya hana wannan cuta ta hanyar allurar rigakafi. Kariya mai inganci tana samuwa.
Yi magana da ƙwararren lafiyar tafiya game da jadawalin da aka ba da shawarar kafin tafiyar ku.
Nemo asibitin allurar rigakafi →Abun ciki a wannan shafin don bayani da ilimi ne kawai. Ba ya zama shawarar likita, gano cuta, ko shawarwarin magani ba. Idan kuna da damuwar lafiya, tuntuɓi ƙwararren ma’aikacin lafiya. Medova ba mai ba da sabis na likitanci ba ne.
Cikakkun sharuɗɗan amfaniRarraba yanki da annobar da ke gudana
Recent epidemiological data from the World Health Organization Global Health Observatory.
Source: WHO GHO OData ↗
And 8 more records
Source: WHO GHO OData ↗
And 2 more records
This data is provided for informational purposes. Please consult official WHO sources for the most current information.
View WHO data source →| Tuta | Ƙasa | Matakin haɗari |
|---|---|---|
| Najeriya | Haɗari mai girma | |
| Tsibiran Solomon | Haɗari mai girma | |
| Saliyo | Haɗari mai girma | |
| Muritaniya | Haɗari mai girma | |
| Senegal | Haɗari mai girma | |
| Angola | Haɗari mai girma | |
| Somaliya | Haɗari mai girma | |
| Binin | Haɗari mai girma | |
| Jamhuriyar Dimokuradiyan Kongo | Haɗari mai girma | |
| Gambiya | Haɗari mai girma |
Kun san allurar rigakafin da kuke bukata? Da kyau. Ba ku sani ba? Ku gaya mana inda kuke tafiya — za mu nemo allurar da ta dace da asibiti. Kyauta, ba tare da wani hakki ba.